Dipeptidyl peptidase 4 (DPP4), an adipokine released by hepatocytes, is known to be upregulated in the liver of patients with obesity and NAFLD, while methylated DPP4 is negatively correlated with the stages of hepatic steatosis and NASH (131). Here, DPP4 is linked to fatty liver disease.